| NCT ID | NCT05090943 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Assistance Publique - Hôpitaux de Paris |
| Condition | Tic Disorders |
| Study Type | OBSERVATIONAL |
| Enrollment | 450 participants |
| Start Date | 2021-12-01 |
| Primary Completion | 2027-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 450 participants in total. It began in 2021-12-01 with a primary completion date of 2027-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to develop the adult tic disorders registry in order to characterize the relationship between tic severity and tic-related impairment in women compared to men with tic disorders.
Eligibility Criteria
Inclusion criteria : 1. Age \>18 years 2. Patients with Tic disorders 3. Given the non-opposition Non Inclusion criteria 1. No affiliation to a French health social insurance 2. Significant congenital disorders that may affect understanding of assessments 3. Patients under guardianship or curatorship
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05090943 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tic Disorders. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05090943 currently recruiting?
Yes, NCT05090943 is actively recruiting participants. Contact the research team at emmanuel.flamand-roze@aphp.fr for enrollment information.
Where is the NCT05090943 trial being conducted?
This trial is being conducted at Clermont-Ferrand, France, Limoges, France, Marseille, France, Paris, France and 3 additional locations.
Who is sponsoring the NCT05090943 clinical trial?
NCT05090943 is sponsored by Assistance Publique - Hôpitaux de Paris. The trial plans to enroll 450 participants.